◀ Back to HSPG2

GHSR — HSPG2

Text-mined interactions from Literome

Chan et al., FEBS Lett 2004 : Furthermore, the ability of the GHSR antagonist D-Lys3-GHRP-6 to inhibit basal PLC and basal ERK1/2 activity suggests that this compound is an inverse agonist
Mear et al., Frontiers in neuroscience 2013 : Interestingly, GHSR-1a constitutive activity activates in turn the downstream PLC , PKC, and CRE signaling pathways and this activation is reversed by the inverse agonist [ D-Arg(1), D-Phe ( 5 ), D-Trp ( 7,9 ), Leu ( 11 ) ] -substance P ( MSP )